RxDoctor Payments Data

Kevin Cooper, MD

Family Medicine · Pascagoula, MSNPI 1023267630

Payments from drug & device makers

$1,617in general payments, 2019–2025

Across 95 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vifor Pharma, Inc.$315
  • AbbVie$268
  • Indivior Inc.$190
  • Novo Nordisk$182
  • AstraZeneca$107
  • Lundbeck LLC$77
  • plus $479 from 17 others

What the payments were for

  • Food & beverage$1,58698%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,617 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$87,326
Medicare patients
110
Services billed
2,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl421$95,945
EliquisApixaban31$32,679
MounjaroTirzepatide31$31,500
OzempicSemaglutide30$30,947
ZubsolvBuprenorphine Hcl/Naloxone Hcl37$26,345
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$20,866
LinzessLinaclotide27$15,446
FarxigaDapagliflozin Propanediol21$14,226
TrulicityDulaglutide11$13,996
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,961
SuboxoneBuprenorphine Hcl/Naloxone Hcl17$8,576
SymbicortBudesonide/Formoterol Fumarate20$5,549
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen118$4,166
Gabapentin325$3,514
Butorphanol Tartrate12$2,553

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$69$45,49642 claims
Novo NordiskOzempic$182$30,94730 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$107$28,73555 claims
AbbVieLinzess, Synthroid$268$17,22349 claims
Indivior Inc.Suboxone$190$8,57617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Pascagoula

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →